Joon Y. Seok

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 82 publications

In Vivo Model of Short-Term Efficacy and Favorable Safety of Botulinum Toxin Type E Compared with Type A.

In Vivo Model of Short-Term Efficacy and Favorable Safety of Botulinum Toxin Type E Compared with Type A.

Journal: Toxins

Published: March 27, 2026

Author Correction: A virtual memory CD8+ T cell-originated subset causes alopecia areata through innate-like cytotoxicity.

Author Correction: A virtual memory CD8+ T cell-originated subset causes alopecia areata through innate-like cytotoxicity.

Journal: Nature immunology

Published: November 05, 2025

Alopecia areata: from immunopathogenesis to emerging therapeutic approaches.

Alopecia areata: from immunopathogenesis to emerging therapeutic approaches.

Journal: Frontiers in immunology

Published: August 07, 2025

Pea Sprout Extract Promotes Hair Follicle Regeneration via Anagen Phase Prolongation and Dual Modulation of Oxidative and Inflammatory Signaling.

Pea Sprout Extract Promotes Hair Follicle Regeneration via Anagen Phase Prolongation and Dual Modulation of Oxidative and Inflammatory Signaling.

Journal: Journal of microbiology and biotechnology

Published: August 07, 2025

Efficacy and Safety of Novel Botulinum Toxin Type A (Protoxin) in the Treatment of Moderate to Severe Glabellar Lines: A Multicenter, Randomized, Double-Blind, Active-Controlled Phase III Study.

Efficacy and Safety of Novel Botulinum Toxin Type A (Protoxin) in the Treatment of Moderate to Severe Glabellar Lines: A Multicenter, Randomized, Double-Blind, Active-Controlled Phase III Study.

Journal: Annals of dermatology

Published: July 16, 2025

Efficacy and safety of autologous adipose-derived stem cells in subjects with moderate to severe atopic dermatitis: a multicenter, randomized, single-blind, placebo-controlled, phase 2 trial.

Efficacy and safety of autologous adipose-derived stem cells in subjects with moderate to severe atopic dermatitis: a multicenter, randomized, single-blind, placebo-controlled, phase 2 trial.

Journal: Stem cell research & therapy

Published: May 30, 2025

Robust effector memory features of human T-bethi B cells induced by repeated mRNA vaccination.

Robust effector memory features of human T-bethi B cells induced by repeated mRNA vaccination.

Journal: iScience

Published: March 08, 2025

Effect of Particulate Matter in Atopic Dermatitis through HDACs and Filaggrin Alteration.

Effect of Particulate Matter in Atopic Dermatitis through HDACs and Filaggrin Alteration.

Journal: Journal of microbiology and biotechnology

Published: February 25, 2025

Air Pollution and Skin Diseases.

Air Pollution and Skin Diseases.

Journal: Annals of dermatology

Published: December 12, 2024

Ameliorative Effects of Escin on Inflammation via Glucocorticoid Receptor (GR) in Atopic Dermatitis (AD) Mouse Model.

Ameliorative Effects of Escin on Inflammation via Glucocorticoid Receptor (GR) in Atopic Dermatitis (AD) Mouse Model.

Journal: Journal of microbiology and biotechnology

Published: October 16, 2024

Emerging Innovations in Acne Management: A Focus on Non-Pharmacological Therapeutic Devices.

Emerging Innovations in Acne Management: A Focus on Non-Pharmacological Therapeutic Devices.

Journal: Journal of Korean medical science

Published: August 16, 2024

Refractory solar lentigines successfully treated with 532-nm nanosecond Nd:YAG Vasculature Salvage Laser Surgery (VSLS) system: Case series.

Refractory solar lentigines successfully treated with 532-nm nanosecond Nd:YAG Vasculature Salvage Laser Surgery (VSLS) system: Case series.

Journal: Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)

Published: July 21, 2024

Showing 1-12 of 82

Last Updated: 09/26/2026